The following clinical trials are associated with All diseases and conditions.
- collapse A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects with Moderate to Severe Hidradenitis Suppurativa
- collapse A Multicentre, Open-label, Randomized, 6-week, Phase IV Study of the Onset and Maintenance of the Antiplatelet Effect of Ticagrelor Compared with Clopidogrel with Aspirin as Background Therapy in Chinese Patients with Non-ST or ST Elevation Acute Coronary Syndromes (ACS)
- collapse A Post Marketing Surveillance to evaluate the safety and efficacy of Brilinta
- collapse Clinical study assessing the safety, tolerability, and pharmacokinetics of intravenous AZD5099 in health subjects
- collapse The asthma control rate achieved by budesonide/formoterol in clinical practice in China
- collapse Dapagliflozin Effect on Cardiovascular Events A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients with Type 2 Diabetes
- collapse A cohort study with a nested case control analysis on the association between acid-suppressing drugs and seizures using THIN database in the UK.
- collapse Nexium capsules Clinical Experience Investigation
- collapse A Phase III, Multicentre, Randomised, Double-Blind, Comparative Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia
- collapse Nexium capsules Specific Clinical Experience Investigation for long-term use concerning prevention of recurrence of gastric ulcer or duodenal ulcer with LDA
